
Who We Are
We are a pre-clinical stage biotechnology startup developing the next generation of nanomedicines based on a proprietary glycogen nanoparticle technology platform - NanoDendrix™
We are world-class physicists, chemists, and biologists, led by a talented management team and an experienced board of directors.
We are a wholly-owned subsidiary of Mirexus Biotechnologies Inc.